ARCHIVES

Mack, to Retire, Calls Budget Proposal an “Act of Retreat”

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | March 19, 1999

Download PDF Visit The Full Archive

Related Articles

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

October 25, 2013

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

NIH Funding Opportunities Listed

March 13, 2009

Sullivan Accuses Tobacco Industry With “Lies, Blue smoke And Mirrors”

June 15, 1990